SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-20-000290
Filing Date
2020-09-24
Accepted
2020-09-24 08:49:08
Documents
9
Period of Report
2020-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gnbt092420form8k.htm 8-K 272613
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 76091
3 EXHIBIT 99.2 ex99_2.htm EX-99.2 22646
4 EXHIBIT 99.3 ex99_3.htm EX-99.3 117117
5 GRAPHIC image_002.gif GRAPHIC 2402
6 GRAPHIC image_003.gif GRAPHIC 22125
7 GRAPHIC image_006.gif GRAPHIC 18120
8 GRAPHIC image_001.gif GRAPHIC 1667
9 GRAPHIC image_005.gif GRAPHIC 18120
  Complete submission text file 0001607062-20-000290.txt   575688
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 201193604
SIC: 2834 Pharmaceutical Preparations